Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03652545
Title Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (REMIND)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications

medulloblastoma

brain stem glioma

choroid plexus carcinoma

central nervous system embryonal carcinoma

high grade glioma

central nervous system cancer

high grade ependymoma

Therapies

MultiTAA-specific T cells

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.